This inventor holds 5 USPTO granted patents. Top assignees: Hoechst Aktiengesellschaft, Behring Diagnositcs Gmbh, Behring Diagnostics Gmbh. Active years: 1997-2001.
Location History:
- Tubingen, DE (1997)
- Neunkirchen, DE (1998 - 2001)
Company Filing History:
2 out of 6,705 
1 out of 1 
1 out of 39 Years Active: 1997-2001
Title: Gerhard Jahn: Innovator in Eukaryotic Expression Systems
Introduction
Gerhard Jahn is a notable inventor based in Neunkirchen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of eukaryotic expression systems. With a total of 5 patents to his name, Jahn's work has had a lasting impact on genetic engineering and molecular biology.
Latest Patents
One of Jahn's latest patents involves an enhancer for eukaryotic expression systems. This enhancer has been located in the upstream region of the major immediate early gene of human cytomegalovirus and has been isolated. It is more active than the enhancer from SV40 and has a wide host cell spectrum. This makes it suitable for eukaryotic expression systems, where it can be incorporated either upstream or downstream of the structural gene or the regulation region.
Career Highlights
Throughout his career, Gerhard Jahn has worked with prominent companies in the biotechnology sector. He has been associated with Hoechst Aktiengesellschaft and Behring Diagnostics GmbH, where he contributed to various innovative projects. His expertise in molecular biology has been instrumental in advancing the capabilities of these organizations.
Collaborations
Jahn has collaborated with several notable individuals in his field, including Bernhard W. Fleckenstein and Walter Schaffner. These collaborations have further enriched his research and development efforts, leading to significant advancements in biotechnology.
Conclusion
Gerhard Jahn's contributions to eukaryotic expression systems and his innovative patents highlight his role as a key figure in biotechnology. His work continues to influence the field and pave the way for future advancements.